Mesoblast (MESO) Payables (2015 - 2025)
Mesoblast's (MESO) quarterly Payables came in at $33.6 million in Q4 2025, up 183.1% year-on-year from $11.9 million in Q4 2024, and up 75.96% quarter-over-quarter from $19.1 million in Q2 2025.
Mesoblast (MESO) Payables (2015 - 2025) Analysis & Trends
Mesoblast has disclosed Payables across 11 years of filings, most recently posting $33.6 million for Q4 2025.
- Payables for Q4 2025 came in at $33.6 million, up 183.1% year-over-year; the trailing twelve-month figure through Dec 2025 was $33.6 million (up 183.1% YoY), and the FY2025 annual result was $19.1 million, up 169.9% from the prior year.
- Payables came in at $33.6 million for Q4 2025 at Mesoblast, up from $19.1 million in the prior quarter.
- In the past five years, Payables ranged from a high of $33.6 million in Q4 2025 to a low of $7.1 million in Q2 2024.
- The 5-year median for Payables is $19.6 million (2021), against an average of $19.1 million.
- Across the five-year window, Payables plunged 64.9% in 2024 and jumped 183.1% in 2025, its largest moves.
- Mesoblast's Payables stood at $20.9 million in 2021, then climbed by 9.91% to $23.0 million in 2022, then sank by 53.2% to $10.8 million in 2023, then advanced by 10.22% to $11.9 million in 2024, then surged by 183.1% to $33.6 million in 2025.
- The last three Payables figures came in at $33.6 million (Q4 2025), $19.1 million (Q2 2025), and $11.9 million (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 1.05 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 300,549.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 83.00 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 8.69 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 489.30 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 34.55 Mn |
| 10 | Mesoblast | 21.68 Bn | 21.55 Bn | - | 33.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 33.58 Mn |
| Jun 30, 2025 | 19.08 Mn |
| Dec 31, 2024 | 11.86 Mn |
| Jun 30, 2024 | 7.07 Mn |
| Dec 31, 2023 | 10.76 Mn |
| Jun 30, 2023 | 20.15 Mn |
| Mar 31, 2023 | 20.97 Mn |
| Dec 31, 2022 | 22.99 Mn |
| Sep 30, 2022 | 17.66 Mn |
| Jun 30, 2022 | 23.08 Mn |
| Mar 31, 2022 | 18.98 Mn |
| Dec 31, 2021 | 20.92 Mn |
| Sep 30, 2021 | 16.26 Mn |
| Jun 30, 2021 | 19.60 Mn |
| Mar 31, 2021 | 24.28 Mn |
| Dec 31, 2020 | 28.61 Mn |
| Sep 30, 2020 | 27.60 Mn |
| Jun 30, 2020 | 24.97 Mn |
| Mar 31, 2020 | 19.48 Mn |
| Dec 31, 2019 | 19.24 Mn |